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Introduction {#sec005}
============

Steroid hormones mediate a wide variety of biological processes and analysis of these in serum and their metabolites in urine are used to detect steroid misuse and disorders of reproductive function, sexual development, electrolyte balance, blood pressure and stress response \[[@pone.0214549.ref001]--[@pone.0214549.ref007]\]. They are small hydrophobic molecules that are synthesized from cholesterol in the testis and ovary, in the adrenal cortex, the placenta and the brain. In humans, the small number of circulating sex steroids, glucocorticoids, corticosterones and mineralocorticoids are converted into a large number of metabolites predominantly excreted via the urine in which they are easily accessible for analysis \[[@pone.0214549.ref008]\]. Major milestones in the development of urinary steroid hormone analysis were built by the advances in transforming the steroids into suitable derivates for GC-MS analysis, e.g. by producing stable oxime-silyl-derivatives, and by the development of a derivative purification method based on lipophilic Sephadex in 1977 \[[@pone.0214549.ref009]--[@pone.0214549.ref011]\]. The long history of urinary steroid analysis and the current role of GC-MS in steroid analysis compared with other analytical techniques as LC-MS/MS were sufficiently addressed in detail elsewhere \[[@pone.0214549.ref012]--[@pone.0214549.ref015]\].

For the correct clinical interpretation of a urinary steroid profile a comparison with reference intervals is necessary. Early efforts have been made to generate such values for the 24-hour excretion of the adult urinary steroid metabolome as summarized by Cedric H. L. Shackleton in 1986 \[[@pone.0214549.ref016]\]. Since then, new data about urinary steroid excretion values measured by GC-MS in adults from the general population were published, however, these data are limited in several respects: 1) the completeness of characterisation of the reference population, 2) the number of analyzed individuals: it ranged from 13 to 120 women and 10 to 120 men per study with overall less than 400 women and less than 400 men in all studies on reference intervals together, 3) the number of analyzed urinary steroids, which remained below 20 in most studies, and 4) the comparability of the laboratory data if several laboratories with different analytical systems were involved in the same study. None of the published reference intervals come from a formal population-based study or was large enough to provide sex- and age-specific reference intervals according to published recommendations \[[@pone.0214549.ref017]\]. While recent decades have seen many new technical developments and enhancements in the field of steroid hormone diagnostics, the method of GC-MS has established itself more and more firmly and is still regarded as the gold-standard allowing a comprehensive analysis of the steroid hormone metabolome \[[@pone.0214549.ref015]\].

The human steroid metabolome is influenced by sex and age and this has been taken into account in the past by providing steroid excretion reference intervals for men and women and for different age groups \[[@pone.0214549.ref018]--[@pone.0214549.ref023]\]. Furthermore, the human steroid metabolome varies at least in part with sleep and / or with the time of day \[[@pone.0214549.ref024], [@pone.0214549.ref025]\], but data supporting this notion for the urinary steroid metabolome in humans are still sparse \[[@pone.0214549.ref026], [@pone.0214549.ref027]\].

This study aims to bridge some of these gaps. The study was conducted 1) to summarize the available data on reference intervals for the urinary steroid excretion from healthy adults of the general population measured by GC-MS during the last 30 years since 1986 and 2) to describe sex- and age-specificity and differences between day and night excretion of a large number of urinary steroid metabolites in a thoroughly characterized general population of European descent measured by GC-MS and 3) to create sex- and age-specific reference intervals for the 24-hour urinary steroid metabolome that can be used in routine clinical work.

Subjects and methods {#sec006}
====================

Literature search for reference intervals of quantitative urinary steroid excretion {#sec007}
-----------------------------------------------------------------------------------

A literature search was conducted to find reference intervals for the urinary steroid metabolome from healthy adults of the general population measured by GC-MS that were published since 1986. Using the PubMed electronic database and Google and Google Scholar, the search included the terms "urine/urinary steroid metabolome", "urine/urinary steroid profile/profiling", "urine/urinary steroids", "normative data", "reference values/intervals", "GC-MS/gas chromatography-mass spectrometry", "steroidogenesis", "steroid synthesis/metabolism" and the trivial and systematic names of the steroid compounds measured in this study.

Study population {#sec008}
----------------

The Swiss Kidney Project on Genes in Hypertension (SKIPOGH) is a multicenter, family-based, cross-sectional study exploring the genetic and non-genetic determinants of blood pressure and renal function in the general adult population \[[@pone.0214549.ref028]\]. 1128 participants were recruited in the regions of Bern and Geneva and in the city of Lausanne in Switzerland from December 2009 to March 2013 by different strategies. In Geneva, a random sample from an index list provided by the population-based Bus Santé study \[[@pone.0214549.ref029]\] was selected, in the city of Lausanne a random sample of volunteers were taken from the population-based CoLaus study \[[@pone.0214549.ref030]\], and in Bern a random sample of participants was selected from the cantonal telephone registry. Inclusion criteria for participation in the study were as follows: 1) age ≥ 18 years; 2) European ancestry; 3) at least 1 and ideally 3 first-degree family members willing to participate. The SKIPOGH study adhered to the Declaration of Helsinki and was approved by the competent institutional ethics committees in Geneva, Lausanne and Bern. All participants provided written informed consent.

Study visit {#sec009}
-----------

The family members were contacted separately and individual appointments for a study visit were made. All participants completed a comprehensive health questionnaire about current and past medical history, medication, nutrition and lifestyle habits. The health questionnaire was checked for completeness and accuracy during the study visit. Body weight was measured to the nearest 0.1 kg with an electronic scale in the morning after an overnight fast in light indoor clothing and height was measured to the nearest 0.5 cm with a wall-mounted stadiometer. Fasting blood venous samples were drawn and were analyzed by standard clinical laboratory methods at each center. The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) 2009 equation was used to calculate the estimated glomerular filtration rate (eGFR)\[[@pone.0214549.ref031]\]. Diabetes was defined as reported, treated, or fasting glycemia ≥7 mmol/L. Hypertension was defined as either systolic blood pressure ≥140 mmHg, diastolic blood pressure ≥90 mmHg, or the use of antihypertensive medications.

Urine collection procedure {#sec010}
--------------------------

A 24-hour urine sample was collected separately for day and night. Participants received two labelled sterile 3-L preservative-free polyethylene containers UriSet 24 (Sarstedt, Nümbrecht, Germany) and standardized written and precise oral instructions. Daytime urine collection started in the morning with the study visit after an overnight fast and ended before bedtime at the same day. Night time urine collection ended with the collection of the first morning urine after waking up. Participants were asked to eat and drink as usual. Containers with daytime and night time urine collection were separately mixed and weighed and aliquoted into 30 mL low density polyethylene Wide-Mouth Bottles (Thermo Scientific, Rochester, New York). Urine aliquots were immediately stored at -80°C and were sent to the steroid laboratory of the Department of Nephrology and Hypertension at the Bern University Hospital, Switzerland, for centralized steroid analysis by GC-MS. Completeness of 24-hour urine collection was assessed based on the amount of urinary creatinine excretion as recently published \[[@pone.0214549.ref032]\].

Quantification of steroid compounds by GC-MS {#sec011}
--------------------------------------------

Urinary excretion of 40 steroid hormone compounds listed in [Table 1](#pone.0214549.t001){ref-type="table"} and depicted in [Fig 1](#pone.0214549.g001){ref-type="fig"} were quantified separately in μg/day and in μg/night time by an *in-house* adapted GC-MS method previously described \[[@pone.0214549.ref013], [@pone.0214549.ref033]\]. [Table 1](#pone.0214549.t001){ref-type="table"} further provides method-validation information for all steroid analytes. The corresponding calibration curves are given in [S1 Fig](#pone.0214549.s001){ref-type="supplementary-material"} and an example of a selected-ion monitoring chromatogram is given in [S2 Fig](#pone.0214549.s002){ref-type="supplementary-material"}.

10.1371/journal.pone.0214549.t001

###### Steroid compounds measured in urine.

![](pone.0214549.t001){#pone.0214549.t001g}

  Trivial name                        Systematic name                                      M       QIon   RT     LOD     LOQ      R^2^    Rec   CV1    CV2
  ----------------------------------- ---------------------------------------------------- ------- ------ ------ ------- -------- ------- ----- ------ ------
  **Progesterones**                                                                                                                                    
  17α-OH-pregnanolone                 3β,17-dihydroxy-5-pregnen-20-one                     334.5   476    17.6   16      54       0.997   88    2.3    15.9
  pregnanetriol                       5β-pregnane-3α,17α,20α-triol                         336.5   435    19.6   180     600      0.999   107   5.5    17.3
  pregnenetriol                       5-pregnene-3β,17α,20α-triol                          334.5   433    23.0   22      72       0.997   101   5.5    29.9
  pregnanetriolone                    3α,17α,20α-trihydroxy-5β-pregnan-11-one              350.5   449    22.0   487     1622     0.994   81    10.5   23.3
  pregnanediol                        5β-pregnane-3α,20α-diol                              316.5   269    19.0   92      307      0.995   108   8.6    20.2
  **Androgens**                                                                                                                                        
  dehydroepiandrosterone              3β-hydroxy-5-androsten-17-one                        288.4   268    15.4   97      324      0.989   85    6.7    19
  16α-OH-dehydroepiandrosterone       3β,16α-dihydroxy-5-androsten-17-one                  304.4   266    18.3   614     2046     0.996   119   3.1    13.8
  androstenediol                      5-androstene-3β,17β-diol                             290.4   239    15.9   109     364      0.997   83    6.5    19.1
  androstenetriol                     5-androstene-3β,16α,17β-triol                        306.4   432    20.6   278     928      0.998   100   6.2    16.1
  testosterone                        17β-hydroxy-4-androsten-3-one                        288.4   389    16.7   506     1686     0.993   85    13.4   31.2
  5α-DH-testosterone                  17β-hydroxy-5α-androstan-3-one                       290.4   391    16.0   544     1812     0.990   85    5.3    22.8
  androstanediol                      5α-androstane-3α,17β-diol                            292.4   331    14.6   258     860      0.993   95    5.9    16.1
  androsterone                        3α-hydroxy-5α-androstan-17-one                       290.4   270    14.4   48      161      0.996   85    6      20.8
  11β-OH-androsterone                 3α,11β-dihydroxy-5α-androstan-17-one                 306.4   268    17.6   204     680      0.994   85    6.2    16.2
  etiocholanolone                     3α-Hydroxy-5β-androstan-17-one                       290.4   270    14.6   29      98       0.992   118   4.8    18.8
  **Estrogens**                                                                                                                                        
  17β-estradiol                       1,3,5(10)-estratriene-3,17β-diol                     272.4   416    16.5   205     682      0.999   81    17.4   37.3
  estriol                             1,3,5(10)-estratriene-3,16α,17β-triol                288.4   504    21.3   96      320      0.997   92    13.2   29
  **Corticosterones**                                                                                                                                  
  TH-11-deoxycorticosterone           3α,21-dihydroxy-5β-pregnan-20-one                    334.5   476    21.2   516     1721     0.995   96    16.5   16.9
  TH-11-dehydrocorticosterone         3α,21-dihydroxy-5β-pregnane-11,20-dione              348.5   490    23.6   105     349      0.996   88    21.2   26.9
  18-OH-TH-11-dehydrocorticosterone   3α,18,21-trihydroxy-5β-pregnane-11,20-dione          364.5   457    26.0   7774    25913    0.999   92    24.5   30.5
  TH-corticosterone                   3α,11β,21-trihydroxy-5β-pregnan-20-one               350.5   564    24.1   266     888      0.995   81    5.4    10
  5α-TH-corticosterone                3α,11β,21-trihydroxy-5α-pregnan-20-one               350.5   564    24.5   60      201      0.993   87    6.4    14.3
  **Mineralocorticoids**                                                                                                                               
  TH-aldosterone                      11β,18-epoxy-3α,18,21-trihydroxy-5β-pregnan-20-one   364.5   506    25.5   1438    4793     0.988   83    12.1   29
  TH-11-deoxycortisol                 3α,17,21-trihydroxy-5β-pregnan-20-one                350.5   564    21.0   388     1294     0.993   89    6.9    12.9
  **Glucocorticoids**                                                                                                                                  
  cortisol                            11β,17,21-trihydroxy-4-pregnene-3,20-dione           362.5   605    30.8   336     1121     0.973   89    5.8    33.9
  6β-OH-cortisol                      6β,11β,17α,21-tetrahydroxy-4-pregnene-3,20-dione     378.5   513    32.0   1144    3814     0.989   81    6.5    40.3
  18-OH-cortisol                      11,17,18,21-tetrahydroxy-4-pregnene-3,20-dione       378.5   344    32.0   38669   128898   0.996   95    12.3   29.9
  20α-DH-cortisol                     11β,17,20α,21-tetrahydroxy-4-pregnen-3-one           364.5   296    32.8   3660    12199    0.994   97    5.2    19.8
  TH-cortisol                         3α,11β,17,21-tetrahydroxy-5β-pregnan-20-one          366.5   652    24.8   122     408      0.995   96    7.1    12.2
  α-cortol                            5β-pregnane-3α,11β,17α,20α,21-pentol                 368.5   343    27.2   249     830      0.999   90    6.1    14
  β-cortol                            5β-pregnane-3α,11β,17α,20β,21-pentol                 368.5   343    26.0   228     758      0.991   96    5.9    14.4
  11β-OH-etiocholanolone              3α,11β-dihydroxy-5β-androstan-17-one                 306.4   268    17.9   127     423      0.994   98    12.9   15.4
  5α-TH-cortisol                      3α,11β,17,21-tetrahydroxy-5α-pregnan-20-one          366.5   652    25.1   40      134      0.995   103   8.8    18.6
  cortisone                           17,21-dihydroxy-4-pregnene-3,11,20-trione            360.5   531    29.0   987     3290     0.973   88    10     25.5
  20α-DH-cortisone                    17α,20α,21-trihydroxy-4-pregnene-3,11-dione          362.5   402    31.6   523     1744     0.990   101   4.9    19.5
  20β-DH-cortisone                    17α,20β,21-trihydroxy-4-pregnene-3,11-dione          362.5   402    30.9   767     2556     0.990   98    5.1    18.4
  TH-cortisone                        3α,17,21-trihydroxy-5β-pregnan-11,20-dione           364.5   578    23.3   422     1408     0.996   96    8.1    11.1
  α-cortolone                         3α,17α,20α,21-tetrahydroxy-5β-pregnane-11-one        366.5   449    25.4   23      77       0.995   101   5.4    17.1
  β-cortolone                         3α,17α,20β,21-tetrahydroxy-5β-pregnane-11-one        366.5   449    26.1   49      162      0.984   106   5.5    15.3
  11-keto-etiocholanolone             3α-hydroxy-5β-androstane-11,17-dione                 304.4   269    16.1   435     1450     0.994   82    3.2    22

The nomenclature used for systematic names is in accordance with the recommendations of the IUPAC commission on the Nomenclature of Organic Chemistry published in 1969 \[[@pone.0214549.ref034]\] amended by the IUPAC--IUB Commission on Biochemical Nomenclature in 1971 \[[@pone.0214549.ref035]\] and again revised in 1989 \[[@pone.0214549.ref036]\]. M: molar mass \[g/mol\]. QIon: quantifier ion \[m/z\]. RT: retention time \[min\]. LOD: limit of detection \[pg per sample\]. LOQ: limits of quantitation \[pg per sample\]. R2: correlation coefficient of the linear calibration curve shown in [S1 Fig](#pone.0214549.s001){ref-type="supplementary-material"}. Rec: Recovery in %. CV1: intraassay coefficient of variation \[%\] (n = 58). CV2: interassay coefficient of variation \[%\] (n = 119). CV1 and CV2 were determined for a urine volume of 1.5 mL. OH: hydroxy, DH: dihydro, TH: tetrahydro.

![Pathways of human steroid hormone biosynthesis.\
Pathways from multiple steroid hormone producing cell types are combined to provide an overall view about the 40 urinary steroid metabolites measured in this study and their biosynthesis processes. Steroid groups are highlighted by colored background as indicated and enzyme activities are displayed in blue color. Abbreviations: DHEA: Dehydroepiandrosterone. The OH in enzyme names indicates a hydroxylase, e.g. 17α-OH: 17α-hydroxylase. The OH in steroid names indicates a hydroxyl group, e.g. 17-OH-pregnanolone: 17-hydroxy-pregnanolone. DH: dihydro; TH: tetrahydro; HSD: hydroxysteroid dehydrogenase; POR: P450 oxidoreductase; Cyt b5: Cytochrome b5; 5α-R: 5α-reductase; 5β-R: 5β-reductase.](pone.0214549.g001){#pone.0214549.g001}

In brief, urine sample preparation consisted of 1) pre-extraction on a Sep-Pak C18 column with the recovery standard medroxyprogesterone, 2) enzymatic hydrolysis with sulfatase and β-glucuronidase/arylsulfatase, 3) extraction of the free steroids from the hydrolysis mixture again on a Sep-Pak C18 cartridge, 4) derivatization with methoxyamine HCl 2% in pyridine at 60°C for one hour after adding the two standards Stigmasterol and 3β5β-TH-aldosterone and derivatization with Trimethylsilylimidazole (TMSI) at 100°C for 16 hours, 5) purification by gel filtration on a Lipidex 5000 column. The derivatized samples were analyzed by mass spectrometric analyses on a gas chromatograph 7890A coupled to a mass selective detector Hewlett-Packard 5975C (both from Agilent Technologies, La Jolla, California, USA) providing selected ion monitoring.

Quality controls of the GC-MS method {#sec012}
------------------------------------

The reproducibility of the applied GC-MS method is continuously monitored by an internal quality control. Urine samples of the same healthy volunteer are measured in parallel in all measurement series and the results are compared with the standard values derived from 15 measurements of this volunteer. The steroid laboratory participates monthly in an external quality control organized by the Foundation for Quality Medical Laboratory Diagnostics skml (Stichting Kwaliteitsbewaking Medische Laboratoriumdiagnostiek, Nijmegen, The Netherlands). Only analytes that fulfilled internal and external quality assessment requirements are included in steroid profiles. For internal quality control, quantitative results have to be within ±20% of the individual reference intervals. The external quality control is evaluated based on multiple of median (MOM) of reported steroids; results had to be better than ±30% of MOM of all participating laboratories for acceptance.

Selection of reference sample group {#sec013}
-----------------------------------

Of the 1128 participants, 33 were excluded from the analyses due to missing data for urinary steroid excretion leaving 1095 participants. Additional participants were excluded from the reference sample group for the following reasons: urine under- or over-collection, pregnancy, self-reported bilateral oophorectomy or bilateral oophorectomy with hysterectomy, Addison's disease (the presence of other hormone disorders was not reported in the cohort), self-reported diagnosis of active malignant disease, self-reported liver disease, estimated glomerular filtration rate less than 30 mL/min per 1.73 m^2^ calculated by CKD-EPI formula, missing data for serum creatinine or urinary creatinine, body mass index \<16 kg/ m^2^ or \> 40 kg/m^2^, \>3 fold elevated γ-glutamyltransferase (\>120 U/L for female and \>180 U/L for male), aspartate or alanine aminotransferases (\>105 U/L for female and \> 150 U/L for male), intake of the following drugs (current intake or in the two previous weeks): hormonal contraceptives, hormones to suppress menstrual bleeding, hormonal menopause treatment, systemic glucocorticoids or mineralocorticoids, 5α-reductase inhibitors, aromatase inhibitors, antiepileptic agents, systemic azole derivatives.

Statistical analysis {#sec014}
--------------------

Baseline characteristics were expressed as numbers and frequency in % or as mean±SD or median;25^th^-75^th^ percentile. The 24-hour urinary steroid hormone metabolite excretion was calculated in μg/24h from day and night time urine collections by the formula (metabolite\[μg/day\]+metabolite\[μg/night\])/(collection time day\[min\]+collection time day\[min\]) × 1440 min. Sex-specific differences of baseline characteristics and 24-hour excretion of steroid hormone metabolites were assessed by chi squared test or Mann--Whitney U test, where appropriate, and a *p* value \<0.05 was considered to be significant. Day and night time excretion rates of steroid analytes expressed in μg/hour were calculated by the formula metabolite\[μg/day\])/collection time day\[min\]×60 min and by the formula metabolite\[μg/night time\]/collection time night time\[min\]×60 min, respectively. Differences between day and night time excretion rates of steroid analytes were analyzed for each sex by Wilcoxon signed-rank test and visualized by boxplots and the correlation between night and day values was further assessed by calculating the Spearman's rank correlation coefficient. Age- and sex-related changes of 24-hour excretion of steroid hormone metabolites were modelled by linear mixed regression models taking family and center effect into account as described in detail in the [S1 Text](#pone.0214549.s010){ref-type="supplementary-material"} and previously by V. Rousson \[[@pone.0214549.ref034]\]. Using the Akaike information criterion the best model for each steroid metabolite was separately selected for men and women and was plotted for different percentiles. Reference intervals based on the 2.5^th^-97.5^th^ percentiles for each metabolite were estimated from the described statistical models for men and women separately and for different age groups. All statistical analyses were conducted using the R software, version 3.3.3 \[[@pone.0214549.ref035]\].

Results {#sec015}
=======

Literature search, measured steroid compounds and pathways of steroidogenesis {#sec016}
-----------------------------------------------------------------------------

The literature search yielded twelve hits for studies that published reference intervals for the urinary steroid excretion from healthy adults of the general population measured by GC-MS since 1986 listed in [S1 Table](#pone.0214549.s005){ref-type="supplementary-material"} \[[@pone.0214549.ref016], [@pone.0214549.ref018]--[@pone.0214549.ref023], [@pone.0214549.ref036]--[@pone.0214549.ref040]\]. These studies combined included data on \<800 participants, thereby precluding the detailed exploration of the relationship of steroid hormone metabolites with sex and age according to published recommendations \[[@pone.0214549.ref017]\] and none of them were reported to be population-based, i.e. coming from a true random sample of the general population on the strength of thoroughly described selection criteria. Studies including reference ranges for comparison purposes but not as the main objective of the publication were not considered in this list.

Characteristics of the reference population {#sec017}
-------------------------------------------

The number of individuals for these references was 838 (459 men, 54.8%). Women were older than men (age mean±SD: 51.2±16.1 versus 47.7±17.6 years, *p* = 0.0054) mainly because younger women using hormonal contraceptives were excluded from the analysis (n = 118). Smoking, hypertension and diabetes were more prevalent in men than in women. Serum electrolytes, parameters of kidney and liver function and parameters of inflammation and blood count were largely within the normal range. The baseline characteristics and laboratory values are shown in [S2 Table](#pone.0214549.s006){ref-type="supplementary-material"}.

Sex- and age-related patterns of the urinary steroid metabolome during 24 hours {#sec018}
-------------------------------------------------------------------------------

The 24-hour excretion of all urinary steroid hormone metabolites was right skewed distributed. The median metabolite excretion by sex compared by Mann--Whitney U test revealed a significant higher excretion for almost all metabolites in men than in women as shown in [S3 Table](#pone.0214549.s007){ref-type="supplementary-material"}, with the exception of pregnanediol (206 vs. 204 μg/24 hours, *p* = 0.57), of TH-aldosterone (456 vs. 378 μg/24 hours, *p* = 0.084), and of 18-OH-cortisol (180 vs. 173 μg/24 hours, *p* = 0.16). The excretion values were visualized by boxplots in [S3(a) Fig](#pone.0214549.s003){ref-type="supplementary-material"}. The relationship of 24-hour excretion of urinary steroid hormone metabolites to age was assessed using a nonparametric fit and revealed a different kind of relationship to age for men and for women for most metabolites as shown in [S3(b) Fig](#pone.0214549.s003){ref-type="supplementary-material"}. Therefore, the 24-hour excretion of urinary steroid hormone metabolites in function of age was modelled separately for men and for women. From the selected models, the 2.5^th^, 10^th^, 25^th^, 50^th^, 75^th^, 90^th^ and 97.5^th^ percentile for each metabolite was plotted on the transformed scale in function of age to get reference curves for men and women depicted in [S4 Fig](#pone.0214549.s004){ref-type="supplementary-material"}. No relationship to age was found for several metabolites, in particular for 11β-OH-androsterone, 18-OH-TH-11-dehydrocorticosterone, cortisol, 5α-TH-cortisol, TH-cortisone, α-cortolone, and β-cortolone in women, and for 20α-DH-cortisol and 20α-DH-cortisone in men, and for 6β-OH-cortisol, 18-OH-cortisol, and β-cortol in women and men. Lower and upper limits of sex- and age-specific reference intervals for the 24-hour excretion of urinary steroid hormone metabolites were derived from the 2.5^th^ and 97.5^th^ percentile for men in [Table 2](#pone.0214549.t002){ref-type="table"} and women in [Table 3](#pone.0214549.t003){ref-type="table"}.

10.1371/journal.pone.0214549.t002

###### Reference intervals for 40 steroid metabolites in 24-hour urine in men.

![](pone.0214549.t002){#pone.0214549.t002g}

  Metabolite, μg/24 hours             N     Age group, years   CF to nmol/24 hours                                                                     
  ----------------------------------- ----- ------------------ --------------------- ------------- ------------ ------------ ------------ ------------ --------
  17α-OH-pregnanolone                 451   75.3--584          65.8--535             57.4--489     49.8--446    43--406      37--369      31.7--335    ×2.990
  pregnanetriol                       395   442--2045          385--1814             334--1607     289--1421    250--1255    215--1106    185--974     ×2.972
  pregnenetriol                       448   54--1213           87.4--1580            47--1127      22.3--769    11.4--559    6.7--441     4.7--380     ×2.990
  pregnanetriolone                    457   6--70.8            6.2--78               6.4--86.3     6.6--96      6.8--108     7--121       7.2--138     ×2.853
  pregnanediol                        457   85.5--653          94.4--708             81.1--625     64--516      55.4--459    52.8--441    52.8--441    ×3.160
  dehydroepiandrosterone              439   36.3--8455         63.7--56319           46.1--17754   24.3--2776   15.3--907    11--445      8.9--287     ×3.467
  16α-OH-dehydroepiandrosterone       448   75.2--1413         155--2139             75.7--1418    30.6--874    13.4--582    6.8--428     4.4--356     ×3.285
  androstenediol                      453   35.4--1036         53.9--1878            42.9--1359    26--673      17--377      12--234      9--160       ×3.444
  androstenetriol                     456   176--1652          214--1927             158--1518     110--1137    77--857      54.2--652    38.6--500    ×3.264
  testosterone                        451   13.1--177          16.6--204             14.3--187     10.1--152    7.2--126     5.3--105     4--90.1      ×3.467
  5α-DH-testosterone                  456   6--91.6            5.4--86.6             4.9--81.8     4.4--77.3    4--72.9      3.6--68.8    3.2--64.8    ×3.444
  androstanediol                      445   44.1--228          49.6--252             42.4--221     34.6--186    28.1--156    22.7--130    18.2--108    ×3.420
  androsterone                        381   1450--5821         1456--5839            1073--4644    759--3594    541--2810    390--2224    285--1786    ×3.444
  11β-OH-androsterone                 447   357--1724          373--1771             376--1780     367--1752    345--1687    313--1589    273--1462    ×3.264
  etiocholanolone                     390   883--5047          794--4743             673--4308     531--3770    385--3165    249--2531    138--1910    ×3.444
  17β-estradiol                       457   0.7--4.5           0.9--5.5              1--6.1        1.1--6.3     1--5.9       0.9--5.6     0.9--5.6     ×3.671
  estriol                             456   1.8--13.8          1.9--14.5             2--15.1       2.2--15.8    2.3--16.5    2.4--17.3    2.5--18.1    ×3.467
  TH-11-deoxycorticosterone           455   3.2--23.3          3.1--22.7             2.9--21.4     2.7--19.5    2.4--17.3    2.2--16.2    2.2--16.2    ×2.990
  TH-11-dehydrocorticosterone         452   49.1--277          49.5--278             46.6--267     40.7--242    32.8--209    28.8--191    28.8--191    ×2.869
  18-OH-TH-11-dehydrocorticosterone   433   14--259            15.1--297             15.7--318     15.7--318    15.1--297    14--259      12.5--212    ×2.743
  TH-corticosterone                   457   52.6--326          58.3--350             59.8--356     57.1--345    50.5--317    48.6--309    60.1--357    ×2.853
  5α-TH-corticosterone                457   155--891           170--976              147--844      128--738     119--681     115--663     115--663     ×2.853
  TH-aldosterone                      456   5.1--79.2          5.4--84               5.5--85.6     5.4--83.9    5.1--79.1    4.6--71.7    4--62.5      ×2.743
  TH-11-deoxycortisol                 457   27.5--145          28.4--152             29.4--160     30.4--168    31.5--176    32.6--185    33.8--194    ×2.853
  cortisol                            457   41.6--243          47.1--282             50--302       49.7--300    47.3--282    48.4--291    54.5--335    ×2.759
  6β-OH-cortisol                      457   35.3--303          35.3--303             35.3--303     35.3--303    35.3--303    35.3--303    35.3--303    ×2.642
  18-OH-cortisol                      424   40.7--638          40.7--638             40.7--638     40.7--638    40.7--638    40.7--638    40.7--638    ×2.642
  20α-DH-cortisol                     457   19.2--136          19.2--136             19.2--136     19.2--136    19.2--136    19.2--136    19.2--136    ×2.743
  TH-cortisol                         371   714--2724          866--3301             966--3682     992--3781    938--3575    918--3501    1047--3992   ×2.729
  α-cortol                            452   127--519           157--638              161--658      164--668     169--688     176--717     186--757     ×2.714
  β-cortol                            453   213--1171          213--1171             213--1171     213--1171    213--1171    213--1171    213--1171    ×2.714
  11β-OH-etiocholanolone              455   29.7--955          15.1--861             27.7--944     43.7--1029   55--1081     59.1--1099   59.1--1099   ×3.264
  5α-TH-cortisol                      381   524--3424          631--3992             578--3715     527--3436    497--3278    488--3226    488--3226    ×2.729
  cortisone                           456   69.2--378          74--404               77--420       77.9--425    76.6--418    73.4--401    68.3--373    ×2.774
  20α-DH-cortisone                    457   11.1--63.3         11.1--63.3            11.1--63.3    11.1--63.3   11.1--63.3   11.1--63.3   11.1--63.3   ×2.759
  20β-DH-cortisone                    457   21.8--127          22.7--131             23.6--135     24.5--140    25.5--145    26.5--149    27.5--154    ×2.759
  TH-cortisone                        407   1543--6080         1643--6378            1667--6449    1611--6285   1483--5902   1297--5332   1072--4623   ×2.743
  α-cortolone                         426   552--2214          587--2338             611--2420     622--2456    618--2443    600--2382    570--2277    ×2.729
  β-cortolone                         427   366--1387          349--1328             332--1271     315--1216    300--1164    285--1114    271--1065    ×2.729
  11-keto-etiocholanolone             455   97.7--1055         67.3--884             85--986       103--1082    109--1113    102--1076    83--975      ×3.285

Reference intervals have been estimated by the described statistical models and are given as 2.5^th^-97.5^th^ percentiles in the unit μg/24 hours for different age groups. N represents the sample number per analyte included in the statistical model. CF: Conversion Factor.

10.1371/journal.pone.0214549.t003

###### Reference intervals for 40 steroid metabolites in 24-hour urine in women.

![](pone.0214549.t003){#pone.0214549.t003g}

  Metabolite, μg/24 hours             N     Age group, years   CF to nmol/24 hours                                                                   
  ----------------------------------- ----- ------------------ --------------------- ------------ ------------ ----------- ------------ ------------ --------
  17α-OH-pregnanolone                 375   18.2--383          28.4--704             27.5--672    16.5--337    9.7--166    8.2--132     8.2--132     ×2.990
  pregnanetriol                       360   173--1156          216--1346             200--1275    135--975     80.9--696   56.8--554    48.3--501    ×2.972
  pregnenetriol                       378   18.7--810          12--661               7.4--535     4.3--429     2.4--341    1.2--268     0.5--207     ×2.990
  pregnanetriolone                    379   4.1--95.7          3--54.5               3.1--57.9    3.4--67      3.6--77.4   3.9--89.4    4.2--103     ×2.853
  pregnanediol                        376   62.9--2180         95.2--5269            94.6--5192   61.7--2101   38.2--830   29.5--520    27.5--460    ×3.160
  dehydroepiandrosterone              377   13.8--1623         15.6--1989            13.6--1578   9.1--834     5.7--409    4.1--242     3.2--168     ×3.467
  16α-OH-dehydroepiandrosterone       379   37.7--1742         33.9--1565            25--1157     15.2--704    8.9--411    5.8--270     4.3--199     ×3.285
  androstenediol                      378   22.5--873          16.8--571             12.6--380    9.5--257     7.2--177    5.6--123     4.3--86.5    ×3.444
  androstenetriol                     378   99.7--1351         72--1051              51.4--813    36.2--625    25.2--476   17.3--361    11.7--271    ×3.264
  testosterone                        367   2.4--55.1          2.7--66.1             2.6--61.8    2.1--45.3    1.6--30.9   1.2--22.8    1.1--18.3    ×3.467
  5α-DH-testosterone                  377   2.9--75.6          2.5--66.9             2.2--59.1    2--52.3      1.8--46.3   1.5--41      1.4--36.2    ×3.444
  androstanediol                      372   8.9--106           10.5--124             9.7--114     7--83.1      4.9--57.7   4--46.7      3.7--44      ×3.420
  androsterone                        349   480--4482          414--3978             307--3138    194--2181    116--1462   75.6--1051   54.3--816    ×3.444
  11β-OH-androsterone                 376   192--1183          192--1183             192--1183    192--1183    192--1183   192--1183    192--1183    ×3.264
  etiocholanolone                     351   543--3870          448--3483             345--3031    243--2540    153--2037   82.1--1551   33.9--1106   ×3.444
  17β-estradiol                       377   0.3--7.6           0.7--26.6             0.9--35.8    0.5--17      0.3--7.1    0.2--5.4     0.2--5.4     ×3.671
  estriol                             374   0.8--36.3          1.6--91.8             1.7--99.5    1--45.3      0.6--19.5   0.5--15      0.5--15      ×3.467
  TH-11-deoxycorticosterone           378   1.8--34.2          2.5--66.1             2.6--69.5    1.9--39      1.4--21.5   1.2--17.9    1.2--17.9    ×2.990
  TH-11-dehydrocorticosterone         379   31.5--240          29.5--228             27.6--216    25.9--205    24.3--194   22.7--184    21.2--174    ×2.869
  18-OH-TH-11-dehydrocorticosterone   342   10--262            10--262               10--262      10--262      10--262     10--262      10--262      ×2.743
  TH-corticosterone                   379   28--226            34.8--261             39.7--285    41.7--294    40.4--288   36.2--268    29.7--235    ×2.853
  5α-TH-corticosterone                379   60.6--556          57--535               53.5--514    50.2--493    47--474     44.1--454    41.2--436    ×2.853
  TH-aldosterone                      378   5.3--83            5.6--86.3             5.5--84.9    5.1--78.8    4.5--69.1   3.7--57.3    2.9--44.9    ×2.743
  TH-11-deoxycortisol                 379   15--97.3           17.6--114             19.8--128    21.4--138    22.2--144   22.1--143    21.1--137    ×2.853
  cortisol                            379   33.7--250          33.7--250             33.7--250    33.7--250    33.7--250   33.7--250    33.7--250    ×2.759
  6β-OH-cortisol                      378   25.6--282          25.6--282             25.6--282    25.6--282    25.6--282   25.6--282    25.6--282    ×2.642
  18-OH-cortisol                      344   32.4--516          32.4--516             32.4--516    32.4--516    32.4--516   32.4--516    32.4--516    ×2.642
  20α-DH-cortisol                     379   16.7--176          16.2--169             15.6--163    15.2--156    14.7--150   14.2--144    13.8--138    ×2.743
  TH-cortisol                         340   336--1677          416--2015             490--2319    550--2560    589--2714   603--2766    588--2711    ×2.729
  α-cortol                            379   92.5--464          95.1--479             97.8--495    101--511     103--528    106--546     109--564     ×2.714
  β-cortol                            378   125--751           125--751              125--751     125--751     125--751    125--751     125--751     ×2.714
  11β-OH-etiocholanolone              378   0.5--612           12.2--756             28.4--860    39.1--916    39.3--917   28.9--863    12.7--760    ×3.264
  5α-TH-cortisol                      362   177--1982          177--1982             177--1982    177--1982    177--1982   177--1982    177--1982    ×2.729
  cortisone                           379   48.3--308          56.3--360             59.4--379    56.7--362    50.2--321   47.9--306    47.9--306    ×2.774
  20α-DH-cortisone                    379   8.6--52.3          8.7--53.1             8.3--49.9    7.4--43.7    6.4--36.5   6--34.2      6--34.2      ×2.759
  20β-DH-cortisone                    379   23.9--145          22.5--136             21.2--129    20--121      18.8--114   17.8--107    16.7--101    ×2.759
  TH-cortisone                        360   900--4654          900--4654             900--4654    900--4654    900--4654   900--4654    900--4654    ×2.743
  α-cortolone                         362   405--1932          405--1932             405--1932    405--1932    405--1932   405--1932    405--1932    ×2.729
  β-cortolone                         369   164--854           164--854              164--854     164--854     164--854    164--854     164--854     ×2.729
  11-keto-etiocholanolone             379   23.6--652          43.4--778             60.8--870    70.9--918    71--919     61--871      43.6--779    ×3.285

Reference intervals have been estimated by the described statistical models and are given as 2.5^th^-97.5^th^ percentiles in the unit μg/24 hours for different age groups. N represents the sample number per analyte included in the statistical model. CF: Conversion Factor.

Sex-related differences in the urinary steroid metabolome at day and night {#sec019}
--------------------------------------------------------------------------

Day and night time excretion values of urinary steroid metabolites were also right skewed distributed and were compared by Wilcoxon signed-rank test. The median excreted amount in μg/hour was significantly higher during the day than at night for 31 metabolites in men and for 35 metabolites in women as shown in [S4 Table](#pone.0214549.s008){ref-type="supplementary-material"}. Higher urinary excretion values during the day compared to night time have been found for cortisol and cortisone and for almost all glucocorticoid metabolites in both sexes. During the day higher excretion rates for both sexes have been also found for the most abundant circulating steroid hormone dehydroepiandrosterone (DHEA) and its two metabolites 16α-OH-DHEA and androstenediol, for the most potent androgen 5α-DH-testosterone and also for androsterone, the most abundant androgen metabolite in urine. For etiocholanolone, which is the second most abundant androgen metabolite in urine, a higher night time excretion rate has been revealed in women, but not in men. Excretion rates for testosterone and 17β-estradiol have not been found to be different in women but to be lower at night time in men. The results were visualized by boxplots in [S3(e) and S3(f) Fig](#pone.0214549.s003){ref-type="supplementary-material"} and summarized in a comprehensive overview in [Fig 2](#pone.0214549.g002){ref-type="fig"}. The correlation between day and night time excretion values assessed by Spearman's rank correlation coefficient in S3(g) and S3(h) Figs and in [S5 Table](#pone.0214549.s009){ref-type="supplementary-material"} revealed a moderate to high positive correlation among most of androgen and progesterone metabolites and a low to moderate positive correlation among most of glucocorticoid metabolites in men and women. Sex specific differences were found for estrogen metabolites, which were much higher positively correlated in women than in men.

![Overview about day and nighttime steroid hormone metabolite excretion in women and men.\
Day and night time excretion values of urinary steroid metabolites in μg/hour were compared by Wilcoxon signed-rank test separately for men and women. Test results are indicated by coloured boxes: a red colour indicates higher excretion values during the day compared to night time, a green colour indicates lower excretion values during the day compared to night time and a yellow colour indicates no statistically significant difference. A white colour indicates that the metabolite has not been measured in the study. The left half of each box represents the test result indicated by colour for women and the right half for men as shown in the legend. Abbreviations: DHEA: Dehydroepiandrosterone. The OH in steroid names indicates a hydroxyl group, e.g. 17-OH-pregnanolone: 17-hydroxy-pregnanolone. DH: dihydro; TH: tetrahydro.](pone.0214549.g002){#pone.0214549.g002}

Discussion {#sec020}
==========

We quantified 40 urinary steroid metabolites by GC-MS in a large number of thoroughly characterized adults of European descent and described the impact of sex and age on each steroid compound and sex-specific differences in day and night time excretions. Furthermore, we created sex- and age-specific reference intervals for these 40 compounds that can be used in routine clinical work as diagnostic tools. According to our literature search of the hitherto available reference intervals for the urinary steroid excretion from adults of the general population measured by GC-MS during the last 30 years since 1986, this is, to our knowledge, the largest study of this kind with such a detailed phenotype and the only one large enough to explore the relationship with age, covering a broad age range in both men and women.

Due to methodological differences, a direct comparison of absolute urinary steroid excretion values obtained by our in-house adapted GC-MS method with values published by other laboratories is possible to only a limited extent. Transferability of reference ranges for the urinary steroid profile could only be guaranteed if our data could be calibrated against a certified reference material which is lacking. For the time being, approximate correction factors could be calculated based on the results of an external quality assessment scheme (available through the Foundation for Quality Medical Laboratory Diagnostics skml) in which our steroid laboratory participates.

However, an inter-methodological comparison of sex- and age-related changes of the urinary steroid metabolome is possible and the studies published by Weykamp et al. and de Jong et al. are suitable for that purpose as both studies provide sex- and age-related reference intervals including 24 or 20 individuals, respectively, per sex- and age-group summarized in [S1 Table](#pone.0214549.s005){ref-type="supplementary-material"} (15, 19). In line with both studies we found an age-related decline of the 24-hour excretion of most progesterones and of androgens. In addition, we obtained similar results for some glucocorticoids with an age-related increase of TH-cortisol and a slight age-related decrease of allo-TH-cortisol with higher values in men for both steroid hormones. In contrast to the study by Weykamp et al. and similarly to the study by de Jong et al, we found a moderate age-related increase for the 24-hour excretion of the 11-deoxycortisol metabolite TH-11-deoxycortisol in men whereas the results in women were more similar in all three studies with regard to age-related changes. Also for 11β-OH-etiocholanolone, which derives mainly from the metabolism of cortisol \[[@pone.0214549.ref041]\], our results suggest a different age-related behaviour for men and women.

Our study reveals higher urinary excretion values for almost all glucocorticoids during the day compared to night time in both sexes whereas the excretion rates of sex steroid hormones present a more heterogeneous picture. A previous study on 10 men and 10 women has shown highest excretion rates for the sum of urinary cortisol metabolites between 12:00 and 15:00 for men and women and lowest excretion rates between 24:00 and 03:00 for men and between 03:00 and 06:00 for women and suggested a delay between serum cortisol levels and the excretion of urinary cortisol metabolites of about 4--5 hours \[[@pone.0214549.ref027]\]. For the 3-hour urinary excretion values of the sum of androsterone and etiocholanolone the same study found a peak after noon and a trough around midnight for men and women. The results of the study are compatible to our results with regard to the circadian excretion of urinary glucocorticoids and of the main urinary androgen androsterone. In addition, our results suggest different circadian excretory behaviours of androgen metabolites, probably also because they are cleared at different rates from the plasma. It has been shown, that after injection of unconjugated radiolabelded \[4-^14^C\]-androsterone and \[4-^14^C\]-etiocholanolone both are cleared to urine very rapidly and at nearly identical rates with a half life of about 20 minutes, whereas the corresponding conjugated steroid glucuronides are excreted much less rapidly and at different rates \[[@pone.0214549.ref042]\].

The observed differences between day and night time steroid excretion values in our study clearly support the presence of a robust circadian rhythm of glucocorticoid synthesis in the adrenal glands \[[@pone.0214549.ref043]\]. Circadian rhythm refers to evolutionarily conserved biological oscillations following a roughly 24-hour cycle and comes from a genetically operated timekeeping system called the "biological clock" \[[@pone.0214549.ref044], [@pone.0214549.ref045]\]. The suprachiasmatic nucleus of the hypothalamus is considered to act as the master clock in the mammalian organism \[[@pone.0214549.ref046]\], Adrenal glands show a circadian rhythm of glucocorticoid synthesis \[[@pone.0214549.ref047]\]. We found a clear separation between day and night time urine steroid excretion, not only for glucocorticoids, but also for most other steroid hormone metabolites that are assumed to be predominantly synthesized in the adrenal glands. In contrast, no tissue-specific circadian rhythm has been so far observed in the mammalian testis \[[@pone.0214549.ref048]--[@pone.0214549.ref050]\], whereas a circadian clock may play a role in steroidogenesis in the mammalian ovary \[[@pone.0214549.ref051]\]. These tissue-specific differences may contribute to the observed heterogeneous picture of urinary androgen and estrogen excretion at day and night time.

In view of methodological aspects our study has several strengths: 1) the analyses of all urine samples in the same laboratory, ensuring comparability of the results from different participants, 2) the confirmation of gas chromatography data by MS, and 3) the high number of subjects that permits a high standard in the creation of the lower and upper limit of reference intervals \[[@pone.0214549.ref017]\]. Moreover, we have been recently able to validate our GC-MS method by multidimensional gas chromatography-time of flight mass spectrometry (GCxGC-TOF MS), a high-resolution method newly developed by our laboratory \[[@pone.0214549.ref052], [@pone.0214549.ref053]\]. Thereby, we are able to exclude for all 40 steroid metabolites analytical problems that may occur due to the effect of matrix interferences in urine or due to the very high chemical similarity of the measured compounds.

The collection completeness is of critical importance especially if urinary excretion is reported as absolute value per collection period (μg/24h). We have made major efforts to achieve a high level of completeness by standardising the collection procedures in all three study centres and procedures were reviewed with each participant subsequently. However, it is not possible to entirely avoid incorrect urine collections and therefore, urinary creatinine excretion was used as a criterion for collection completeness. By the detection of under- and over-collected urine samples on the basis of the lower and upper limit of the 95% CI of the 24-hour creatinine excretion at least extreme collection errors could be excluded from the analyses. The applied regression model to predict 24-hour urinary creatinine excretion was recently developed with data from more than 1000 adults of European descent from the Swiss Survey on Salt and was validated with the participants of SKIPOGH providing a good fit \[[@pone.0214549.ref032]\]. This comparability of the SKIPOGH population to another independent and large Swiss cross-sectional population sample group underlines the reproducibility of our reference sample group and strengthens the level of confidence in urine collection completeness in this study.

Our study has several limitations. The study was restricted to participants of European descent. Due to the cross-sectional design of the study, urinary steroid hormone excretion data from the same participants at different ages are not available. Information about the phase of menstrual cycle were not collected and therefore reference ranges established for premenopausal women cover the whole period of the menstrual cycle. However, in a study including ten healthy white women of age 20--40 years with regular endogenous menstrual cycles between 24--34 days, the range of 24-hour urinary excretion of androgens and glucocorticoids was in a similar range as measured in our study and no differences were found between menstrual, follicular and luteal phase of the menstrual cycle for the urinary excretion of androgens and of the five glucocorticoids cortisol, cortisone, TH-cortisol, allo-TH-cortisol and TH-cortisone \[[@pone.0214549.ref021]\]. Moreover, a study comparing salivary cortisol after awaking revealed no differences between 11 women in the luteal phase and 12 women in the follicular phase of the menstrual cycle \[[@pone.0214549.ref054]\] and in another study it was consciously avoided to record the phase of menstrual cycle because previous unpublished analyses did not reveal an impact on urinary glucocorticoid and androgen metabolites \[[@pone.0214549.ref027]\]. In contrast, levels of plasma estrogens are associated with menstrual characteristics \[[@pone.0214549.ref055]\] and therefore the urinary excretion of estrogens would be expected to be influenced by the menstrual cycle phase as suggested by a study on six premenopausal women with highest values during the periovulatory phase and lowest values during the early follicular phase \[[@pone.0214549.ref056]\]. Further studies are necessary to confirm these results and to light up the impact of menstrual cycle also on the urinary excretion of progesterones, estrogens, corticosterones, and mineralocorticoids. Additionally, it would also be preferable to use isotopically labelled internal standards for more robust and accurate quantification (e.g. one standard per compound class).

Despite these limitations, our study clearly expands the current knowledge on the urinary steroid hormone metabolome in adults from the general population. The study introduces new reference ranges for a large number of urinary steroid hormones and can serve as an important tool in clinical practice.

Supporting information {#sec021}
======================

###### Calibration curves.

Calibration curves are shown for all analytes injected on column in the range from 39 to 20000 fmol. Crosses indicate data points, the solid line represents the linear regression curve and the dotted lines the 95% confidence interval. Axes are plotted in logarithmic scale (base 10).

(PDF)

###### 

Click here for additional data file.

###### Example of a selected-ion monitoring chromatogram.

A plot of the sum of ion abundances for the selected compound-specific ions on the vertical axis versus the retention time of each characteristic ion on the horizontal axis simultaneously obtained by a GC-MS analysis of urinary steroid derivatives is shown. Multiple chromatographic peaks indicate the elution of numerous individual steroid compounds. By knowing the retention time for a given steroid indicated in the table, the members of the urinary steroid profile can be distinguished. Some steroid compounds are labeled. QIon: quantifier ion \[m/z\]. RT: retention time \[min\].

(PDF)

###### 

Click here for additional data file.

###### Descriptive analyses of steroid compounds.

A descriptive analysis of the 40 steroid compounds measured in urine is shown including one steroid compound per page. Panel (a): boxplots, steroid (log-scale) by sex; Panel (b): Gasser-Müller nonparametric fits and scatter plots, steroid (log-scale) by age and by sex; Panels (c) and (d): boxplots, transformed steroid for men and women according to optimal power transformation; outliers are plotted as black dots; Panels (e) and (f): steroid (log-scale) by day and night time for men and women; Panels (g) and (h): Spearman correlation of transformed steroid night vs day. Abbreviations used: M = men; W = women; D = day; N = night; TR = optimal power transformation; nout = number of outliers; sk = skewness; ku = kurtosis; delta = robust estimate of mean difference expressed in standard deviations; rho = Spearman correlation coefficient; n = sample size.

(PDF)

###### 

Click here for additional data file.

###### Reference curves of steroid compounds.

Reference curves of the 40 steroid compounds measured in urine are shown including one steroid compound per page. The percentiles 2.5, 10, 25, 50, 75, 90 and 97.5 of the steroid compounds in function of age and sex are shown on a log-scale. To improve comparison the same scale has been used for men and women.

(PDF)

###### 

Click here for additional data file.

###### Published urinary steroid excretion reference values.

Quantitative urinary steroid excretion values measured by GC-MS and published since 1986 in adults are shown. Abbreviations: GC: gas chromatography, MS: mass spectrometry, F: female, M: male, d: days, y: years.

(PDF)

###### 

Click here for additional data file.

###### Baseline characteristics of the reference sample group.

The number of participants is indicated for each characteristic and sex group. Categorical variables are described by % and continuous variables by their mean±standard deviation or by their median;25^th^-75^th^ percentiles. Sex-specific differences were determined by chi squared test or Mann--Whitney U test, and the corresponding *p* values are indicated.

(PDF)

###### 

Click here for additional data file.

###### Sex specific differences in 24 hours urinary excretion of steroid hormone metabolites.

The available number of participants is indicated for each metabolite stratified for sex. Metabolites in the unit μg/24 hours are described by their median;25^th^-75^th^ percentile. Between-group differences were determined by Mann--Whitney U test, and the corresponding *p* values are indicated.

(PDF)

###### 

Click here for additional data file.

###### Day and nighttime specific differences in urinary excretion of steroid hormone metabolites in men and women.

The available number of participants is indicated for each metabolite stratified for sex. Metabolites in the unit μg/hour are described by their median;25^th^-75^th^ percentile. Within-sex differences were determined by Wilcoxon signed-rank test, and the corresponding *p* values are indicated.

(PDF)

###### 

Click here for additional data file.

###### Correlation between day and nighttime urinary excretion (μg/hour) of steroid hormone metabolites in men and in women.

The available number of participants is indicated for each metabolite stratified for sex. The correlation between day and nighttime excretion values was assessed by Spearman's rank correlation coefficient ρ (rho). Rho values were ranked in ascending order within each sex group. Metabolites were colored by steroid groups as indicated.

(PDF)

###### 

Click here for additional data file.

###### Statistical methods.

The statistical methods applied are described in detail.

(PDF)

###### 

Click here for additional data file.
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